zł
72.20
Jan 2
New Key Statistics Module, Z-Score and F-Score
WAR:PCR Key Ratios
Market Cap zł M | 1,433.41 |
Enterprise Value zł M | 1,871.26 |
P/E(ttm) | 11.23 |
PE Ratio without NRI | 11.27 |
Forward PE Ratio | 15.96 |
Price/Book | 1.06 |
Price/Sales | 0.68 |
Price/Free Cash Flow | 7.25 |
Price/Owner Earnings | 8.46 |
Payout Ratio % | 1.10 |
Revenue (TTM) zł M | 1,995.00 |
EPS (TTM) zł | 6.10 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | 19.60 |
5-y EBITDA Growth Rate % | 22.30 |
y-y EBITDA Growth Rate % | -56.50 |
EV-to-EBIT | 10.82 |
EV-to-EBITDA | 5.46 |
PEG | 0.51 |
Shares Outstanding M | 19.85 |
Net Margin (%) | 6.06 |
Operating Margin % | 9.46 |
Pre-tax Margin (%) | 7.03 |
Quick Ratio | 1.26 |
Current Ratio | 1.61 |
ROA % (ttm) | 4.89 |
ROE % (ttm) | 9.08 |
ROIC % (ttm) | 7.90 |
Dividend Yield % | 9.28 |
Altman Z-Score | 2.64 |
WAR:PCR Number of Guru Trades
WAR:PCR Volume of Guru Trades
Gurus Latest Trades with WAR:PCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WAR:PCR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data